|
Magnesium in PDB 5vof: Desgla-XAS195A Bound to Aptamer 11F7T and RivaroxabanEnzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban
All present enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban:
3.4.21.6; Protein crystallography data
The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof
was solved by
S.Krishnaswamy,
S.Kumar,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5vof:
The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban
(pdb code 5vof). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof: Jump to Magnesium binding site number: 1; 2; Magnesium binding site 1 out of 2 in 5vofGo back to Magnesium Binding Sites List in 5vof
Magnesium binding site 1 out
of 2 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban
Mono view Stereo pair view
Magnesium binding site 2 out of 2 in 5vofGo back to Magnesium Binding Sites List in 5vof
Magnesium binding site 2 out
of 2 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban
Mono view Stereo pair view
Reference:
R.Gunaratne,
S.Kumar,
J.W.Frederiksen,
S.Stayrook,
J.L.Lohrmann,
K.Perry,
K.M.Bompiani,
C.V.Chabata,
N.K.Thalji,
M.D.Ho,
G.Arepally,
R.M.Camire,
S.Krishnaswamy,
B.A.Sullenger.
Combination of Aptamer and Drug For Reversible Anticoagulation in Cardiopulmonary Bypass. Nat. Biotechnol. V. 36 606 2018.
Page generated: Mon Dec 14 21:18:36 2020
ISSN: ISSN 1546-1696 PubMed: 29863725 DOI: 10.1038/NBT.4153 |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |